Evan Roberts Sells 2,681 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,681 shares of the firm’s stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of $27.95, for a total transaction of $74,933.95. Following the completion of the transaction, the chief operating officer now directly owns 769,993 shares in the company, valued at approximately $21,521,304.35. This represents a 0.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Evan Roberts also recently made the following trade(s):

• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.
• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The shares were sold at an average price of $21.03, for a total transaction of $38,758.29.

Phreesia Stock Down 5.9 %

Shares of NYSE:PHR opened at $26.75 on Friday. The firm has a market cap of $1.55 billion, a P/E ratio of -18.20 and a beta of 0.94. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $29.16. The business has a fifty day simple moving average of $22.87 and a 200 day simple moving average of $22.63. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm’s revenue was up 16.6% compared to the same quarter last year. During the same period last year, the company earned ($0.58) earnings per share. Analysts predict that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PHR has been the topic of several recent analyst reports. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research note on Friday. Truist Financial boosted their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Citigroup raised their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday. JMP Securities reiterated a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. Finally, KeyCorp raised their target price on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $31.00.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently modified their holdings of PHR. Bank of New York Mellon Corp boosted its position in Phreesia by 8.4% during the second quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock valued at $4,546,000 after acquiring an additional 16,614 shares during the last quarter. Rhumbline Advisers boosted its position in shares of Phreesia by 1.0% during the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after purchasing an additional 853 shares in the last quarter. Hsbc Holdings PLC acquired a new stake in Phreesia during the second quarter worth approximately $301,000. Sei Investments Co. grew its stake in Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares during the period. Finally, Ensign Peak Advisors Inc lifted its stake in Phreesia by 3.2% in the second quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock valued at $477,000 after buying an additional 700 shares during the period. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.